BB Biotech reported a net loss of CHF 241 mn for Q1 2025. The share price closed the quarter at a 14.1% discount to NAV, broadly in line with year-end 2024. The share price performance for the quarter ...

Background Article 44 of the EU’s Securitisation Regulation (“SECR”) requires the Joint Committee of the European Supervisory Authorities (“ESAs”) ...

Agthia’s decision to retain the Riviere brand underscores the value placed on its established market presence. The integration of Riviere is expected to ... The addition of Riviere represents a ...

Nigeria's foreign exchange (FX) market having undergone a dramatic transformation under the current leadership of the Central ...

The ESMA Consultation comes at an interesting time when the possibility of streamlining template reporting is being considered as part of the ...

Understanding your audience’s position in the marketing funnel and selecting ... So, you’ve downloaded the template, edited it to your team’s requirements, and are ready to fill out the ...

The move is expected to complement its existing business and strengthen its position in the market. Further, as part of its business overhaul, the company announced changes to its operating ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

As the broader market builds anticipation for an altseason breakout, early positioning becomes key. Tokens with utility, working development, and low presale pricing tend to lead the way once ...

Through this partnership, RockerFunder will leverage its expertise in industry communications, investor outreach, and strategic market positioning to support SecureTech’s growth. Services will include ...